CoChat

Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia

Open access

The DOI matches its Crossref record; 52 of the 55 references it cites were found in a registry or an index; none of the 18 sources its claims cite is checked for support yet.

Abstract

Diagnosis and treatment of Plasmodium falciparum infections are required for effective malaria control and are pre-requisites for malaria elimination efforts; hence we need to monitor emergence, evolution and spread of drug- and diagnostics-resistant parasites. We deep sequenced key drug-resistance mutations and 1,832 SNPs in the parasite genomes of 609 malaria cases collected during a diagnostic-resistance surveillance study in Ethiopia. We found that 8.0% (95% CI 7.0–9.0) of malaria cases were caused by P. falciparum carrying the candidate artemisinin partial-resistance kelch13 (K13) 622I mutation, which was less common in diagnostic-resistant parasites mediated by histidine-rich proteins 2 and 3 (pfhrp2/3) deletions than in wild-type parasites (P = 0.03). Identity-by-descent analyses showed that K13 622I parasites were significantly more related to each other than to wild type (P < 0.001), consistent with recent expansion and spread of this mutation. Pfhrp2/3-deleted parasites were also highly related, with evidence of clonal transmissions at the district level. Of concern, 8.2% of K13 622I parasites also carried the pfhrp2/3 deletions. Close monitoring of the spread of combined drug- and diagnostic-resistant parasites is needed.

Overview

CoChat Summary

TL;DR

Targeted deep sequencing of 609 Ethiopian *Plasmodium falciparum* samples found that 8.0% carried the candidate artemisinin partial-resistance K13 622I mutation, with evidence of recent clonal expansion. A small subset of K13 622I parasites also carried pfhrp2/3 deletions, raising concern for combined drug- and diagnostic-resistant malaria.

Key findings

  • K13 622I was present in 8.0% (95% CI 7.0–9.0) of malaria cases and was confirmed in all 3 surveyed regions and all 12 districts; regional prevalence was highest in Amhara (9.8%, 95% CI 8.2–11.4), followed by Tigray (8.4%, 95% CI 6.2–10.5) and Gambella (3.6%, 95% CI 2.1–4.8).
  • K13 622I was less common among pfhrp2/3 double-deleted parasites (5/110, 4.5%) than non-deleted parasites (26/223, 11.6%), though not significantly so (Fisher’s exact P = 0.07); district-level mean prevalence was higher among non-deleted parasites (P = 0.03), and permutation analysis showed a −8.7% mean difference (P = 0.02). The abstract reports that 8.2% of K13 622I parasites also carried pfhrp2/3 deletions.
  • Identity-by-descent analysis showed K13 622I parasites were significantly more related to each other than wild-type parasites (mean pairwise IBD 0.43 vs 0.08; Mann–Whitney P < 0.001), consistent with recent expansion and clonal spread. Overall, 10.6% of pairs (4,758/44,883) were highly related (IBD ≥ 0.25), and pfhrp2/3 double-deleted parasites showed 43.7% of comparisons at IBD ≥ 0.25 versus 4.3% for non-deleted parasites.
  • Most samples carried the pfmdr1 NFD haplotype (83%), including 98% (60/61) of K13 622I mutant parasites; pfcrt-N326S was carried by 98% of K13 622I and 81% of wild-type parasites (Fisher’s exact P < 0.001).

Methods

  • The study used molecular inversion probe (MIP) sequencing on 920 dried blood spot samples from three Ethiopian regions (Amhara = 598, Gambella = 83, Tigray = 239) previously assessed for pfhrp2/3 deletions; after filtering, 609 samples and 1,395 genome-wide SNPs were used for relatedness analysis.
  • Two MIP panels were used: a drug-resistance panel (814 probes) targeting antimalarial-resistance mutations/genes and a genome-wide SNP panel (1,832 probes) for parasite connectivity and relatedness; sequencing was performed on Illumina NextSeq 550, with variant calling via MIPtools and freebayes.
  • Analyses included weighted prevalence estimates adjusted for RDT-concordant/discordant sampling, complexity-of-infection estimation, PCA and Fst for population structure, and identity-by-descent/network analysis for parasite relatedness.

Limitations

  • Stated in the paper: travel histories and samples from neighbouring countries were not included, so importation of resistant strains is not addressed in detail; the parent study was designed to evaluate RDT failure and may introduce selection bias, including undersampling of low-parasitaemia/submicroscopic infections or oversampling of monogenomic infections; and the three studied regions have relatively higher transmission and do not represent all of Ethiopia, limiting extrapolation.
  • Also stated in the paper: the within-host fitness comparison was limited because polygenomic infections were rare (n = 16).
  • Evident from the text: MIP sequencing coverage was parasite-density-dependent, and the cross-sectional surveillance design cannot directly establish the origins or causal drivers of the observed mutation expansions.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41564-023-01461-4

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Prevalence of K13 and key drug-resistance mutations in Ethiopia. a, Spatial distribution of K13 622I mutation at the district (pie charts) and regional (bar plot) levels. Colours indicate mutation status and pie chart size is proportional to sample size per district. The black triangle indicates the location where K13 622I mutation was reported previously. b, Prevalence of non-synonymous mutations across the K13 gene, coloured according to WHO ACT resistance marker category. K13 gene annotation shows 1–350 amino-acid residues in the poorly conserved Plasmodium-specific region and 350–726 residues in the beta propeller domain where validated resistance mutations are located. c, Prevalence of mutations across four key P. falciparum genes (colours) associated with commonly used antimalarial drugs.
Fig. 1 Prevalence of K13 and key drug-resistance mutations in Ethiopia. a, Spatial distribution of K13 622I mutation at the district (pie charts) and regional (bar plot) levels. Colours indicate mutation status and pie chart size is proportional to sample size per district. The black triangle indicates the location where K13 622I mutation was reported previously. b, Prevalence of non-synonymous mutations across the K13 gene, coloured according to WHO ACT resistance marker category. K13 gene annotation shows 1–350 amino-acid residues in the poorly conserved Plasmodium-specific region and 350–726 residues in the beta propeller domain where validated resistance mutations are located. c, Prevalence of mutations across four key P. falciparum genes (colours) associated with commonly used antimalarial drugs.CC BY · PubMed Central
Fig. 2 Frequency of key drug-resistance mutation combinations. The number of times (top right) each combination of mutations (bottom right) was observed is displayed, including K13 622I, pfmdr1 N86 (wild), 184F (mutant) and D1246 (wild); and pfcrt genes. Only samples (n = 446) with complete genotypes across all loci representing monogenomic or the dominant haplotype in polygenomic infections are shown.
Fig. 2 Frequency of key drug-resistance mutation combinations. The number of times (top right) each combination of mutations (bottom right) was observed is displayed, including K13 622I, pfmdr1 N86 (wild), 184F (mutant) and D1246 (wild); and pfcrt genes. Only samples (n = 446) with complete genotypes across all loci representing monogenomic or the dominant haplotype in polygenomic infections are shown.CC BY · PubMed Central
Fig. 3 K13 622I mutation among pfhrp2/3-deleted and non-deleted parasite populations. a, Comparison of mean K13 622I mutation prevalence (P = 0.03, unpaired Student’s t-test, two-tailed) between pfhrp2/3 double (n = 119) and pfhrp2/3 non-deleted (n = 223) parasite populations by district across three regions in Ethiopia. b, Relationship between pfhrp2/3 double-deleted parasite prevalence and K13 622I mutation prevalence by district. Prevalence estimates are weighted (see Supplementary Table 2). Orange points represent districts where parasites harbouring both pfhrp2/3 deletions and K13 622I mutations are observed. The boxplot centre lines in a show the median value, the upper and lower bounds show the 25th and 75th quantiles, respectively, and the upper and lower whiskers show the largest and smallest values, respectively.
Fig. 3 K13 622I mutation among pfhrp2/3-deleted and non-deleted parasite populations. a, Comparison of mean K13 622I mutation prevalence (P = 0.03, unpaired Student’s t-test, two-tailed) between pfhrp2/3 double (n = 119) and pfhrp2/3 non-deleted (n = 223) parasite populations by district across three regions in Ethiopia. b, Relationship between pfhrp2/3 double-deleted parasite prevalence and K13 622I mutation prevalence by district. Prevalence estimates are weighted (see Supplementary Table 2). Orange points represent districts where parasites harbouring both pfhrp2/3 deletions and K13 622I mutations are observed. The boxplot centre lines in a show the median value, the upper and lower bounds show the 25th and 75th quantiles, respectively, and the upper and lower whiskers show the largest and smallest values, respectively.CC BY · PubMed Central
Fig. 4 PCA of P. falciparum populations annotated by K13 622I and pfhrp2/3 deletion genotypes. Colours indicate pfhrp2/3 deletion status and shape indicates K13 622I mutation status. The percentage of variance explained by each principal component is presented.
Fig. 4 PCA of P. falciparum populations annotated by K13 622I and pfhrp2/3 deletion genotypes. Colours indicate pfhrp2/3 deletion status and shape indicates K13 622I mutation status. The percentage of variance explained by each principal component is presented.CC BY · PubMed Central
Fig. 5 Pairwise IBD sharing and relatedness networks suggest clonal transmission and expansion of K13 622I parasites. a, Pairwise IBD sharing across all three regions of Ethiopia. The plot shows the probability that any two isolates are identical by descent, where the x axis indicates IBD values ranging 0–1 and the y axis indicates the frequency (%) of isolates sharing IBD. The inset highlights highly related parasite pairs from out of total pairs (n = 44,883), with a heavy tail in the distribution and some highly related pairs of samples having IBD ≥ 0.95. b, Pairwise IBD sharing within parasites carrying K13 622I vs wild type (P < 0.001, two-tailed, Mann–Whitney U-test). Boxes indicate the interquartile range, the line indicates the median, the whiskers show the 95% confidence intervals and black dots show outlier values. P value determined using Mann–Whitney test is shown. c, Relatedness network of highly related parasite pairs (n = 150) sharing IBD ≥ 0.95. Colours correspond to K13 622I mutant and wild parasites. d, Relatedness network of only K13 622I parasite pairs (n = 31) sharing IBD ≥ 0.95 at the district level/local scale. Colours correspond to districts across three regions in Ethiopia. In both c and d, each node identifies a unique isolate and an edge is drawn between two isolates if they share their genome above IBD ≥ 0.95. Isolates that do not share IBD ≥ 0.95 of their genome with any other isolates are not shown.
Fig. 5 Pairwise IBD sharing and relatedness networks suggest clonal transmission and expansion of K13 622I parasites. a, Pairwise IBD sharing across all three regions of Ethiopia. The plot shows the probability that any two isolates are identical by descent, where the x axis indicates IBD values ranging 0–1 and the y axis indicates the frequency (%) of isolates sharing IBD. The inset highlights highly related parasite pairs from out of total pairs (n = 44,883), with a heavy tail in the distribution and some highly related pairs of samples having IBD ≥ 0.95. b, Pairwise IBD sharing within parasites carrying K13 622I vs wild type (P < 0.001, two-tailed, Mann–Whitney U-test). Boxes indicate the interquartile range, the line indicates the median, the whiskers show the 95% confidence intervals and black dots show outlier values. P value determined using Mann–Whitney test is shown. c, Relatedness network of highly related parasite pairs (n = 150) sharing IBD ≥ 0.95. Colours correspond to K13 622I mutant and wild parasites. d, Relatedness network of only K13 622I parasite pairs (n = 31) sharing IBD ≥ 0.95 at the district level/local scale. Colours correspond to districts across three regions in Ethiopia. In both c and d, each node identifies a unique isolate and an edge is drawn between two isolates if they share their genome above IBD ≥ 0.95. Isolates that do not share IBD ≥ 0.95 of their genome with any other isolates are not shown.CC BY · PubMed Central
Fig. 6 Pairwise IBD sharing and relatedness networks suggest independent emergence and clonal spread of pfhrp2/3-deleted parasites. a, Pairwise IBD sharing by pfhrp2/3 deletion status (***P < 0.001, **P < 0.01, Kruskal–Wallis test). Boxes indicate the interquartile range, the line indicates the median, the whiskers show the 95% confidence intervals and black dots show outlier values. b, Relatedness network of highly related parasite pairs sharing IBD ≥ 0.95. Each node identifies a unique isolate and an edge is drawn between two isolates if they share their genome at IBD ≥ 0.95. Isolates that do not share IBD ≥ 0.95 of their genome with any other isolates are not shown. Colour codes correspond to pfhrp2/3 deletion status. c, Relatedness network of pfhrp2/3 double-deleted parasite pairs with IBD ≥ 0.95 at district level/local scale. Colours correspond to districts across three regions of Ethiopia.
Fig. 6 Pairwise IBD sharing and relatedness networks suggest independent emergence and clonal spread of pfhrp2/3-deleted parasites. a, Pairwise IBD sharing by pfhrp2/3 deletion status (***P < 0.001, **P < 0.01, Kruskal–Wallis test). Boxes indicate the interquartile range, the line indicates the median, the whiskers show the 95% confidence intervals and black dots show outlier values. b, Relatedness network of highly related parasite pairs sharing IBD ≥ 0.95. Each node identifies a unique isolate and an edge is drawn between two isolates if they share their genome at IBD ≥ 0.95. Isolates that do not share IBD ≥ 0.95 of their genome with any other isolates are not shown. Colour codes correspond to pfhrp2/3 deletion status. c, Relatedness network of pfhrp2/3 double-deleted parasite pairs with IBD ≥ 0.95 at district level/local scale. Colours correspond to districts across three regions of Ethiopia.CC BY · PubMed Central
Extended Data Fig. 1 Plasmodium falciparum incidence rate in 2018 and distribution of sequenced samples (n = 609). Colors in the heat map indicate P. falciparum incidence rate per thousand cases in Africa year 2018. Zoomed Ethiopian map shows spatial distribution of sequenced samples at district level (colour dots in map) and regional level (color bar plot) and heat map indicate P. falciparum incidence rate per thousand cases in 2018 at regional level. Data source for this figure (https://data.malariaatlas.org)53.
Extended Data Fig. 1 Plasmodium falciparum incidence rate in 2018 and distribution of sequenced samples (n = 609). Colors in the heat map indicate P. falciparum incidence rate per thousand cases in Africa year 2018. Zoomed Ethiopian map shows spatial distribution of sequenced samples at district level (colour dots in map) and regional level (color bar plot) and heat map indicate P. falciparum incidence rate per thousand cases in 2018 at regional level. Data source for this figure (https://data.malariaatlas.org)53.CC BY · PubMed Central
Extended Data Fig. 2 PCR parasitemia distribution and association between sequencing coverage and parasitaemia. A) Density plot showing parasitemia distribution with median parasitemia = 1411 parasite/ul for all successfully sequenced samples (n = 609). B) Association between sequencing coverage and parasitaemia. The MIP sequencing success is parasitaemia dependent as shown in the heatmap color. n represents the number of samples used in each panel. The boxplot centre lines in B, show the median value, the upper and lower bounds show the 25th and 75th quantiles, respectively, and the upper and lower whiskers show the largest and smallest values, respectively.
Extended Data Fig. 2 PCR parasitemia distribution and association between sequencing coverage and parasitaemia. A) Density plot showing parasitemia distribution with median parasitemia = 1411 parasite/ul for all successfully sequenced samples (n = 609). B) Association between sequencing coverage and parasitaemia. The MIP sequencing success is parasitaemia dependent as shown in the heatmap color. n represents the number of samples used in each panel. The boxplot centre lines in B, show the median value, the upper and lower bounds show the 25th and 75th quantiles, respectively, and the upper and lower whiskers show the largest and smallest values, respectively.CC BY · PubMed Central
Extended Data Fig. 3 Sample and SNP missingness across sequenced samples using genome-wide MIP panel. A) Samples with >50% low-coverage loci were dropped as shown broken read line. B) Variant sites were then assessed by the same means in terms of the proportion of low-coverage samples, and sites with >50% low-coverage samples were dropped. Broken read line shows 50% threshold criteria we used to remove samples and loci from downstream analyses.
Extended Data Fig. 3 Sample and SNP missingness across sequenced samples using genome-wide MIP panel. A) Samples with >50% low-coverage loci were dropped as shown broken read line. B) Variant sites were then assessed by the same means in terms of the proportion of low-coverage samples, and sites with >50% low-coverage samples were dropped. Broken read line shows 50% threshold criteria we used to remove samples and loci from downstream analyses.CC BY · PubMed Central
Extended Data Fig. 4 Successfully sequenced samples across three regions in Ethiopia and retained genome wide loci. A) Heatmap color shows samples (n = 609, columns) and loci (n = 1395, rows) coverage retained after filtering (Extended Data Fig. 3) for downstream analysis. B) Distribution of retained SNPs across Plasmodium falciparum chromosomes. The plot shows distribution of 1395 retained high quality biallelic SNPs across the 14 P. falciparum chromosomes within 0.025 Mb window size. Color coded from light grey for masked regions with no SNPs to red for regions containing high number SNPs per chromosome.
Extended Data Fig. 4 Successfully sequenced samples across three regions in Ethiopia and retained genome wide loci. A) Heatmap color shows samples (n = 609, columns) and loci (n = 1395, rows) coverage retained after filtering (Extended Data Fig. 3) for downstream analysis. B) Distribution of retained SNPs across Plasmodium falciparum chromosomes. The plot shows distribution of 1395 retained high quality biallelic SNPs across the 14 P. falciparum chromosomes within 0.025 Mb window size. Color coded from light grey for masked regions with no SNPs to red for regions containing high number SNPs per chromosome.CC BY · PubMed Central
Extended Data Fig. 5 Complexity of infections. A) Distribution Number of clones per sample across all genotyped samples (n = 609) showing most of isolates carrying one clone (COI = 1). B) Cumulative within-infection FWS fixation showing majority of isolates classified as monogenomic (FWS > 0.95). Number of clones per sample. C) Spatial heterogeneity of mean complexity of infections per district across three regions in Ethiopia. Vertical lines show 95% confidence intervals. Samples size per district ranges 9–167 (see supplementary table 1).
Extended Data Fig. 5 Complexity of infections. A) Distribution Number of clones per sample across all genotyped samples (n = 609) showing most of isolates carrying one clone (COI = 1). B) Cumulative within-infection FWS fixation showing majority of isolates classified as monogenomic (FWS > 0.95). Number of clones per sample. C) Spatial heterogeneity of mean complexity of infections per district across three regions in Ethiopia. Vertical lines show 95% confidence intervals. Samples size per district ranges 9–167 (see supplementary table 1).CC BY · PubMed Central
Extended Data Fig. 6 Prevalence of Pfdhfr and Pfdhps mutations across three regions in Ethiopia. A) UpSet plots showing the number of times each combination of mutations was seen for Pfdhfr and Pfdhps. B) Spatial distribution of Pfdhps A581G mutation at district level. Colors indicate mutation status and size of pie chart is proportional to sample size per district.
Extended Data Fig. 6 Prevalence of Pfdhfr and Pfdhps mutations across three regions in Ethiopia. A) UpSet plots showing the number of times each combination of mutations was seen for Pfdhfr and Pfdhps. B) Spatial distribution of Pfdhps A581G mutation at district level. Colors indicate mutation status and size of pie chart is proportional to sample size per district.CC BY · PubMed Central
Extended Data Fig. 7 Prevalence of Pfcrt mutations across three regions in Ethiopia. The UpSet plot shows the number of times each combination of mutation was observed within pfcrt (A), and prevalence of these mutations by pfhrp2/3 status (B). Note that the prevalence within pfhrp2-/3+ was not estimated due to small sample size.
Extended Data Fig. 7 Prevalence of Pfcrt mutations across three regions in Ethiopia. The UpSet plot shows the number of times each combination of mutation was observed within pfcrt (A), and prevalence of these mutations by pfhrp2/3 status (B). Note that the prevalence within pfhrp2-/3+ was not estimated due to small sample size.CC BY · PubMed Central
Extended Data Fig. 8 Population structure of P. falciparum in Ethiopia. A) Principal component analysis P. falciparum populations per region. Colors indicate sample origin and shape indicates K13 622I mutation status (circle indicates wild and diamond indicates mutant). Percentage of variance explained by each principal component presented (%). B) Percent of overall variance explained by the first 10 principal components during PCA.
Extended Data Fig. 8 Population structure of P. falciparum in Ethiopia. A) Principal component analysis P. falciparum populations per region. Colors indicate sample origin and shape indicates K13 622I mutation status (circle indicates wild and diamond indicates mutant). Percentage of variance explained by each principal component presented (%). B) Percent of overall variance explained by the first 10 principal components during PCA.CC BY · PubMed Central
Extended Data Fig. 9 PCA loading values. PC1 (A) and PC2 (B) are shown by SNP. Cutoffs show SNPs that highly contribute to positive or negative distribution of samples in the PC plots.
Extended Data Fig. 9 PCA loading values. PC1 (A) and PC2 (B) are shown by SNP. Cutoffs show SNPs that highly contribute to positive or negative distribution of samples in the PC plots.CC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 11 Not checked · 79 Own results and interpretations

47 more claims

Create a free account to see all 90 claims and to verify the 18 references still open.

See all claims — free account
  • It may state two separate claims as one. 27
  • Probably not a substantial claim. 14

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

9 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 52 references

Cited by

See all 213

Metadata

Authors
Fola, A. A., Feleke, S. M., Mohammed, H., Brhane, B. G., Hennelly, C. M., Assefa, A., Crudal, R. M., Reichert, E., Juliano, J. J., Cunningham, J., Mamo, H., Solomon, H., Tasew, G., Petros, B., Parr, J. B., & Bailey, J. A.
Affiliations
  • Brown University (US)
  • Ethiopian Public Health Institute (ET)
  • University of North Carolina at Chapel Hill (US)
  • Harvard University (US)
  • World Health Organization (CH)
  • Addis Ababa University (ET)
  • Federal Ministry of Health (ET)
Corresponding author
Bailey, Jeffrey A.
Venue
Nature Microbiology
Published
2023-08-28
Volume
8
Issue
10
Pages
1911-1919
ISSN
2058-5276 (ISSN-L)
OpenAlex
W4386225325
Cited by
213
References
55
Citations by year
2026: 72 · 2025: 69 · 2024: 57 · 2023: 14
FWCI
38.85
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Microbiology (publishedVersion, cc-by)
  • medRxiv (submittedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Greater South Information System
Funders
  • Bill and Melinda Gates Foundation (OPP1209843)
  • Global Fund to Fight AIDS, Tuberculosis and Malaria (EPHI 5405)
  • World Health Organization
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases (R01AI132547, R01AI177791, K24AI134990)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Life Sciences › Immunology and Microbiology › Parasitology › Bird parasitology and diseases
  • Life Sciences › Immunology and Microbiology › Parasitology › Vector-borne infectious diseases
Keywords
Plasmodium falciparum, artemisinin resistance, antimicrobial resistance surveillance, identity by descent, clonal transmission, parasite genomics, Ethiopia, malaria elimination
MeSH terms
Antimalarials, Ethiopia, Humans, Plasmodium falciparum, Protozoan Proteins, Malaria, Falciparum, Artemisinins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia. https://app.cochat.ai/papers/10.1038/s41564-023-01461-4
The paper
Fola, A. A., Feleke, S. M., Mohammed, H., Brhane, B. G., Hennelly, C. M., Assefa, A., Crudal, R. M., Reichert, E., Juliano, J. J., Cunningham, J., Mamo, H., Solomon, H., Tasew, G., Petros, B., Parr, J. B., & Bailey, J. A. (2023). Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia. Nature Microbiology. https://doi.org/10.1038/s41564-023-01461-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.